FREQMAX provides an alternative approach for determining high-resolution allele frequency thresholds in carrier screening.

Abstract excerpt

As whole-genome data become available for increasing numbers of individuals across diverse populations, the list of genomic variants of unknown significance (VOUS) continues to grow. One powerful tool in VOUS interpretation is determining whether an allele is too common to be considered pathogenic. As genetic and epidemiological parameters vary across disease models, so too does the pathogenic allele frequency...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ciliary Motility Disorders
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator